First Trust NYSE Arca Biotech Index
(PCQ: FBT)
57.33
+0.80
+1.42%
MORE ON FBT
DETAILS
| Symbol | Value ($) |
|---|---|
| Previous Close | 56.53 |
| Open | 56.68 |
| Day's High | 57.43 |
| Day's Low | 56.40 |
| Volume | 24,493 |
| Bid | 56.04 |
| Bid Size | 800 |
| Ask | 58.69 |
| Ask Size | 500 |
| 52-Wk High | 61.53 |
| 52-Wk Low | 41.44 |
| Beta | 0.97 |
| YTD NAV Return | +24.39 |
| YTD Market Return | +24.50 |
| Inception Date | 6/19/2006 |
| Shares Outstanding | 5.25 Mil |
- Last trade 6/18/2013 4:37 PM ET
INVESTMENT OBJECTIVE
| NA |
|---|
| The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index(SM). The fund will normally invest at least 90% of its net assets plus the amount of any borrowings for investment purposes in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. The fund is non-diversified. |
PERFORMANCE
| Symbol | Value ($) |
|---|---|
| 1 Month | -3.97% |
| 3 Months | 7.87% |
| 1 Year | 31.20% |
| 3 Years* | 19.96% |
| 5 Years* | 20.29% |
- * Annualized returns
- Data through 6/18/2013 12:00 AM ET
VIDEO ON MSN MONEY
TOP NEWS
Morningstar Ratings
| Symbol | Value ($) |
|---|---|
| Category | Health |
| Morningstar Risk | High |
| Morningstar Rating | |
| Morningstar Return | Above Average |
HOLDINGS
| Symbol | Value ($) |
|---|---|
| Stocks | 100.00% |
| Cash | 0.00% |
| Fixed Income | 0.00% |
| Other | 0.00% |
TOP 10 HOLDINGS
| NAME | % NET ASSETS |
|---|---|
| Illumina, Inc. | 5.73% |
| United Therapeutics Corporation | 5.51% |
| Biogen Idec Inc | 5.35% |
| Immunogen, Inc. | 5.31% |
| Alexion Pharmaceuticals, Inc. | 5.26% |
| Dendreon Corp | 5.12% |
| Incyte Corp Ltd | 5.07% |
| InterMune, Inc. | 5.03% |
| Regeneron Pharmaceuticals, Inc. | 5.03% |
| Biomarin Pharmaceutical, Inc. | 4.98% |
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
RECENT QUOTES
WATCHLIST
You're not signed in
You’re not signed in to MSN Money, so you’re seeing the Watchlist that is tied to your computer. For a more consistent Watchlist experience, sign in to MSN Money.
Learn more
Sponsored by:
FBT BUZZ
MARKET UPDATE
[BRIEFING.COM] The major averages ended higher across the board as the S&P 500 advanced 0.8%. Equities climbed steadily since the opening bell as investors prepared for tomorrow's policy decision from the Federal Reserve. Although chatter in recent w
...
More
MORE MARKET NEWS
Sponsored by:
INVESTING TIPS AND TOOLS



